Federal Register notice: FDA makes available a final guidance entitled Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer (DT...
FDA issues an Import Alert against all drugs from Chinas Chengdu KeCheng Fine Chemicals and a Warning Letter about its continuing failure to respond t...
Eli Lilly says new Phase 2 data on weight-loss candidate retatrutide met primary and secondary endpoints.
Federal Register notice: FDA sends to OMB an information collection revision entitled Imports and Electronic Import Entries.
Federal Register notice: FDA withdraws the approval of a Gemini Laboratories NDA for Oxandrin (oxandrolone) tablets and four ANDAs that reference the ...
FDA warns Cambridge, MD-based Safe Chain Solutions about violations of the Drug Supply Chain Security Act in its work as a wholesale drug distributor.
FDA publishes a guidance on how to present more consumer-friendly efficacy and risk information in direct-to-consumer promotional labeling and ads.
Two Oncology Center of Excellence executives describe the benefits of the new QCARD initiative intended to improve study proposals that use real-world...
